title: Fetal antipsychotic exposure in a changing landscape: seeing the future.
abstract: Pregnant women and their fetuses are increasingly likely to be exposed to antipsychotics. However, safety data remain limited. This editorial suggests that, in future, well-designed observational pharmaco-epidemiology is our best chance of illuminating risk for exposed populations and of informing decision-making for women and clinicians.
authors: Kathryn M
authors: KM
authors: Abel
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology; D014150:Antipsychotic Agents / Q000009:adverse effects*; D015988:Cohort Effect; D002658:Developmental Disabilities / Q000139:chemically induced; D005260:Female; D005544:Forecasting; D006801:Humans; D018811:Maternal Exposure; D055118:Medication Adherence; D001523:Mental Disorders / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents